Electroporation for Cancer Treatment Real World Registry

Sponsor
Mirai Medical
Study ID
NCT04929912
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Key Dates

First listed
Jun 18, 2021
Start date
Jun 24, 2021
Status verified
Jan 2025
Primary completion
Dec 24, 2026
Completion
Jun 24, 2036

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Incidence of Treatment-Emergent Adverse Events (CTCAE) [ Time Frame: 5 years ]

Central Contacts

Find similar trials

Nationwide
Skin cancer trialsOncology trialsSkin cancer trialsDermatology trials

Related Studies